4.7 Article

Temporal changes in factors associated with COVID-19 vaccine hesitancy and uptake among adults in Hong Kong: Serial cross-sectional surveys

Related references

Note: Only part of the references are listed.
Article Infectious Diseases

Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study

Anika Singanayagam et al.

Summary: Vaccination reduces the risk of delta variant infection and accelerates viral clearance. However, fully vaccinated individuals with breakthrough infections may still have similar peak viral loads as unvaccinated cases and can efficiently transmit the infection.

LANCET INFECTIOUS DISEASES (2022)

Article Biotechnology & Applied Microbiology

Vaccine hesitancy in the era of COVID-19: could lessons from the past help in divining the future?

Charles Shey Wiysonge et al.

Summary: Vaccine hesitancy poses a significant threat to global health during the COVID-19 pandemic, hindering efforts to achieve herd immunity and potentially prolonging the crisis. Tailored strategies to address vaccine hesitancy based on local determinants are essential for successful vaccination campaigns.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2022)

Review Public, Environmental & Occupational Health

Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature

Kalpana Thapa Bajgain et al.

Summary: Hypertension, diabetes, and cardiovascular diseases are the most common comorbidities among COVID-19 positive patients across major epicenters worldwide. While having comorbidities is associated with increased disease severity, there is no clear association found between these risk factors and increased risk of fatality.

AMERICAN JOURNAL OF INFECTION CONTROL (2021)

Article Immunology

Acceptance of the COVID-19 vaccine based on the health belief model: A population-based survey in Hong Kong

Martin C. S. Wong et al.

Summary: The study found that the acceptance of COVID-19 vaccine is influenced by factors such as the Health Belief Model, trust in the healthcare system, new vaccine platforms and manufacturers, and self-reported health outcomes. Government recommendation is identified as the most significant driving factor for vaccine acceptance.

VACCINE (2021)

Article Immunology

Change of Willingness to Accept COVID-19 Vaccine and Reasons of Vaccine Hesitancy of Working People at Different Waves of Local Epidemic in Hong Kong, China: Repeated Cross-Sectional Surveys

Kailu Wang et al.

Summary: The study found a decreasing trend in willingness to accept the COVID-19 vaccine, with increasing concerns about vaccine safety and growing compliance of personal protection behaviors being the main reasons. Clerical/service/sales workers were less likely to accept the vaccine compared to other occupations. It is suggested that more education and favorable policies should be provided to the general working population for vaccination, especially for those who are not professional and are frequently exposed to crowds.

VACCINES (2021)

Article Medicine, General & Internal

Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study

Sara Y. Tartof et al.

Summary: This study aimed to assess the overall and variant-specific effectiveness of the BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19-related hospital admissions among members of a healthcare system in California. The effectiveness of the vaccine remained high against hospital admissions even up to 6 months after full vaccination, despite a decline in effectiveness against SARS-CoV-2 infections over time, which was likely due to waning immunity rather than the delta variant escaping vaccine protection.

LANCET (2021)

Article Psychology, Biological

Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA

Sahil Loomba et al.

Summary: Recent online misinformation about COVID-19 vaccines has been found to decrease intent to vaccinate among adults in the UK and the USA, particularly among those who were initially willing to get vaccinated. Certain sociodemographic groups are more negatively impacted by misinformation, and scientifically-sounding misinformation has a stronger effect on reducing vaccination intent.

NATURE HUMAN BEHAVIOUR (2021)

Article Immunology

The Changing Acceptance of COVID-19 Vaccination in Different Epidemic Phases in China: A Longitudinal Study

Jiahao Wang et al.

Summary: Public acceptance for COVID-19 vaccination in China remained high during different epidemic phases, but the intention for immediate vaccination declined significantly due to concerns about vaccine safety. Information about vaccination safety from authoritative sources, doctor's recommendations, and vaccination convenience were important in addressing vaccine hesitancy and promoting successful herd immunity for the general population in China.

VACCINES (2021)

Article Medicine, General & Internal

Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant

S. A. Madhi et al.

Summary: The ChAdOx1 nCoV-19 vaccine did not provide significant protection against mild-to-moderate Covid-19 caused by the B.1.351 variant, with an efficacy of 10.4%. The incidence of serious adverse events was balanced between the vaccine and placebo groups.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Letter Medicine, General & Internal

Public Trust andWillingness to Vaccinate Against COVID-19 in the US From October 14, 2020, to March 29, 2021

Michael Daly et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Medicine, General & Internal

Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults A Randomized Clinical Trial

Nawal Al Kaabi et al.

Summary: This interim analysis of an ongoing randomized trial in the UAE and Bahrain evaluated the efficacy of two inactivated COVID-19 vaccines in preventing symptomatic cases and adverse events in healthy adults. The study found that both vaccines significantly reduced the risk of symptomatic COVID-19 compared to the control group, with efficacy rates of 72.8% and 78.1%. Serious adverse events were rare across all groups.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Editorial Material Medicine, General & Internal

Considerations in boosting COVID-19 vaccine immune responses

Philip R. Krause et al.

LANCET (2021)

Editorial Material Biochemistry & Molecular Biology

Understanding COVID-19 vaccine hesitancy

Shingai Machingaidze et al.

Summary: The new study reveals the complexities of COVID-19 vaccine hesitancy and acceptance in low-, middle-, and high-income countries.

NATURE MEDICINE (2021)

Article Biochemistry & Molecular Biology

COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries

Julio S. Solis Arce et al.

Summary: The acceptance of COVID-19 vaccines in LMICs is higher compared to the United States and Russia, with a focus on personal protection and concerns about side effects. Healthcare workers are the most trusted sources of guidance in LMICs for COVID-19 vaccines, suggesting that prioritizing vaccine distribution to these countries could help advance global immunization coverage.

NATURE MEDICINE (2021)

Article Medicine, General & Internal

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months

S. J. Thomas et al.

Summary: BNT162b2 vaccine remains highly effective and safe over the course of 6 months post-vaccination, with efficacy rates ranging from 86% to 100% across different demographics and risk factors for Covid-19. The vaccine also shows a high efficacy against severe disease, with particularly promising results observed in South Africa against the B.1.351 variant.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Editorial Material Medicine, General & Internal

Covid-19 vaccination hesitancy

Mohammad S. Razai et al.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Article Immunology

Vaccine hesitancy: Definition, scope and determinants

Noni E. MacDonald

VACCINE (2015)